Description
A selective inhibitor of class I PI3K isoforms (IC50s = 17, 53, and 6 nM for p110β, -γ, and -δ, respectively); orally bioavailable, showing strong antitumor activity against human cancer xenografts in mice
Formal name: 2-(difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole
Synonyms:
Molecular weight: 417.4
CAS: 475110-96-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|PI3K||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling